Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (68 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 22 Jan 2015 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Motilal Oswal ELSS Tax Saver Fund |
|---|---|
| 22 Jan 2015 | ₹100.00 |
| 09 Jan 2016 | ₹110.51 |
| 27 Dec 2016 | ₹124.26 |
| 14 Dec 2017 | ₹174.32 |
| 01 Dec 2018 | ₹156.72 |
| 19 Nov 2019 | ₹174.18 |
| 05 Nov 2020 | ₹167.25 |
| 23 Oct 2021 | ₹251.00 |
| 11 Oct 2022 | ₹227.12 |
| 28 Sep 2023 | ₹269.57 |
| 14 Sep 2024 | ₹429.40 |
| 02 Sep 2025 | ₹383.02 |
| 20 Aug 2026 | ₹406.70 |
| Metric | Motilal Oswal · Direct · IDCW NAV ₹41.07 Very High risk ★★★☆☆ | Category median ELSS · 68 funds |
|---|---|---|
| +5.43% | +2.22% | |
| +16.44% | +9.76% | |
| +11.09% | +8.88% | |
| +12.31% | +10.68% | |
| +12.88% | +10.64% | |
| +12.75% | — | |
| +13.11% | +11.55% | |
| +12.59% | +12.14% | |
| +13.14% | +10.94% | |
| Risk | ||
| 19.85% | 14.08% | |
| 0.50 | 0.32 | |
| 0.67 | 0.44 | |
| -37.76% | -35.52% | |
| Nifty 500 | — | |
| +3.33% | -1.42% | |
| 1.23 | 0.96 | |
| 129.7% | 91.4% | |
| 127.1% | 94.7% | |
| 0.98% | 1.17% | |
| ₹4,627Cr | ₹694.87Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹500 | — | |
| 10% | 33% | |
| Rakesh Shetty | — | |
| 22 Jan 2015 | — | |
| 30 | — | |
| 42.5% | — | |
| 0.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.